Clinical Trial Update: Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS [Phase 4]

View source ↗

Summary

Phase 4 study evaluating an algorithm-based strategy for discontinuing eculizumab in children and adults with atypical hemolytic uremic syndrome (aHUS) has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Nantes University Hospital | Conditions: Atypical Hemolytic Uremic Syndrome | Phase 4 | Status: COMPLETED